Pamela P. Palmer
2013
In 2013, Pamela P. Palmer earned a total compensation of $2M as Chief Medical Officer at AcelRx Pharmaceuticals, a 88% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $174,643 |
|---|---|
| Option Awards | $1,432,226 |
| Salary | $409,000 |
| Other | $7,650 |
| Total | $2,023,519 |
Palmer received $1.4M in option awards, accounting for 71% of the total pay in 2013.
Palmer also received $174.6K in non-equity incentive plan, $409K in salary and $7.7K in other compensation.
Rankings
In 2013, Pamela P. Palmer's compensation ranked 3,860th out of 12,286 executives tracked by ExecPay. In other words, Palmer earned more than 68.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,860 out of 12,286 | 69th |
Division Manufacturing | 1,309 out of 4,612 | 72nd |
Major group Chemicals And Allied Products | 355 out of 1,466 | 76th |
Industry group Drugs | 248 out of 1,160 | 79th |
Industry Pharmaceutical Preparations | 202 out of 890 | 77th |
Source: SEC filing on April 28, 2016.
Palmer's colleagues
We found five more compensation records of executives who worked with Pamela P. Palmer at AcelRx Pharmaceuticals in 2013.
2013
Richard King
AcelRx Pharmaceuticals
Chief Executive Officer
2013
David Chung
AcelRx Pharmaceuticals
Chief Commercial Officer
2013
James Welch
AcelRx Pharmaceuticals
Chief Financial Officer
2013
Badri Dasu
AcelRx Pharmaceuticals
Chief Engineering Officer
2013
Lawrence Hamel
AcelRx Pharmaceuticals
Chief Development Officer
News
AcelRx Pharmaceuticals CEO Vincent Angotti's 2023 pay slips 7% to $1.2M
April 29, 2024
AcelRx Pharmaceuticals CEO Vincent Angotti's 2022 pay falls 47% to $1.3M
August 28, 2023
AcelRx Pharmaceuticals CEO Vincent Angotti's 2021 pay jumps 39% to $2.4M
June 3, 2022
AcelRx Pharmaceuticals CEO Vincent Angotti's 2019 pay jumps 22% to $2.1M
April 24, 2020
AcelRx Pharmaceuticals CEO Vincent Angotti's 2018 pay falls 26% to $1.7M
May 14, 2019